Quinolines and aza-quinolines as CRTH2 receptor modulators
US9290453B2 · kind B2 · utility
0Cited by
9References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 19, 2011 |
| Grant date | Mar 22, 2016 |
| Priority date | — |
| Expiry date | Jan 29, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/107
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides certain quinolines and aza-quinolines of the Formula (I), and their pharmaceutically acceptable salts, wherein E, J1, Ja, Jb, R2, R3, R22, Ra, Rb, Rc, Rd, X, Y, b, n, and q are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions associated with uncontrolled or inappropriate stimulation of CRTH2 function.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.